Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Losartan shows limited benefit in preclinical models of Geleophysic dysplasia.

Scientific reports·2026
Same author

RNU4ATAC-opathy: Clinical, molecular and transcriptomic insights from a large cohort.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Distal enhancer-insulator module of GDF6 is essential for cochlear formation.

JCI insight·2026
Same author

Revertant Mosaicism Obscures Long-Awaited Molecular Confirmation of Diamond-Blackfan Anemia.

American journal of medical genetics. Part A·2026
Same author

Genetic correlation analysis of Alzheimer's disease and stroke implicates PHLPP1 as a shared locus in individuals of African ancestry.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

The involvement of TNFRSF25 in age-related hearing loss.

Human genetics·2026

Related Experiment Video

Updated: Jan 8, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.5K

Next-generation sequencing in genetic hearing loss.

Denise Yan1, Mustafa Tekin, Susan H Blanton

  • 1Department of Otolaryngology, Miller School of Medicine, University of Miami, Miami, Florida 33136, USA.

Genetic Testing and Molecular Biomarkers
|June 7, 2013
PubMed
Summary

The $1000 genome era and next-generation sequencing enable comprehensive genetic analysis for hearing loss (HL). This advances the identification of novel genes responsible for syndromic and nonsyndromic HL.

More Related Videos

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

19.7K
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.3K

Related Experiment Videos

Last Updated: Jan 8, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.5K
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

19.7K
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.3K

Area of Science:

  • Genomics
  • Medical Genetics
  • Otolaryngology

Background:

  • Genetic disorders, particularly heterogeneous Mendelian conditions like deafness, present challenges in identifying causative genes and mutations.
  • Traditional gene arrays have limitations in comprehensively analyzing all known deafness-related genes.
  • The decreasing cost of genome sequencing ($1000 genome) and advancements in sequencing technology present new opportunities.

Purpose of the Study:

  • To review genomic technologies applicable to the genetic diagnosis of hearing loss (HL).
  • To highlight the potential of these technologies in discovering novel genes for syndromic and nonsyndromic HL.
  • To discuss how advanced genomic approaches overcome limitations of previous methods.

Main Methods:

  • Review of current genomic technologies, including target-enrichment and next-generation sequencing.
  • Application of these technologies for genetic diagnosis in hearing loss.
  • Utilizing genomic data for the discovery of new genes associated with HL.

Main Results:

  • Next-generation sequencing and target-enrichment methods allow for complete analysis of known deafness genes.
  • These technologies facilitate the identification of private mutations and novel genes.
  • The $1000 genome era promises a new wave of discoveries in Mendelian disorders.

Conclusions:

  • Genomic technologies are revolutionizing the identification of genes underlying genetic disorders, especially heterogeneous conditions like deafness.
  • Advanced sequencing approaches enable comprehensive genetic diagnosis and discovery of novel genes for hearing loss.
  • The future holds significant potential for breakthroughs in understanding the genetic basis of syndromic and nonsyndromic hearing loss.